BSE: GRANULES - Granules India Limited

半年間の収益性: +12.76%

プロモーションスケジュール Granules India Limited

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology.

さらに詳しく
Granules India Limited was founded in 1984 and is based in Hyderabad, India.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

EBITDA 6.1
EV/EBITDA 5.3
ISIN INE101D01020
Industry Pharmaceuticals
P/BV 1.7
P/E 9.37
P/S 1.21
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 25.99
Див.доход ао 0.4754
Дивиденд ао 1.5
Сайт https://www.granulesindia.com
Цена ао 567.5
Число акций ао 0.24237 млрд
1日あたりの価格変動: +3.47% (567.5)
週ごとの価格変動: -4.79% (616.75)
月ごとの料金変更: +0.3075% (585.4)
3ヶ月間の価格変動: -2.1% (599.8)
半年間の価格変動: +12.76% (520.75)
年間の価格変動: +36.53% (430.1)
3年間の価格推移: +80.79% (324.8)
5年間の価格推移: +374.89% (123.65)
10年間の価格推移: 0% (587.2)
年初からの価格変動: -0.7521% (591.65)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 2.08 7
P/BV 2.9 6
P/E 23.09 6
EV/EBITDA 9.42 8
合計: 6.13

効率

名前 意味 学年
ROA, % 7.34 2
ROE, % 12.57 4
合計: 2.67

配当金

名前 意味 学年
Div yield, % 0.4754 1.2
DSI 0.9286 9.29
合計: 3.4

義務

名前 意味 学年
Debt/EBITDA 1.32 8
合計: 8.2

成長の衝動

名前 意味 学年
収益性 Revenue, % 72.79 8
収益性 Ebitda, % 52.2 7
収益性 EPS, % 38.73 5
合計: 4.8
さらに詳しく

ETF 共有, % 年間の利益率, % 配当金, %
iShares MSCI India Small-Cap ETF 0.2039 5.44 0.96163
SPDR S&P Emerging Markets Small Cap ETF 0.08617 3.85 3.03583
WisdomTree India Earnings Fund 0.07585 9.16 1.65591
Dimensional Emerging Markets Value ETF 0.07511 17.07 4.19508
iShares MSCI Emerging Markets Small-Cap ETF 0.07375 7.67 2.7853
Avantis Emerging Markets Value ETF 0.04379 14.12 4.22231
SPDR Portfolio Emerging Markets ETF 0.04218 10.83 3.1879
Vanguard FTSE All-World ex-US Small-Cap ETF 0.04 9.39 3.09932
Dimensional Emerging Markets Core Equity 2 ETF 0.03849 15.96 3.34087
Avantis Emerging Markets Equity ETF 0.03261 7.19 3.60513
Dimensional World ex U.S. Core Equity 2 ETF 0.01559 13.06 3.62488
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01338 12.46 3.59676
SPDR Portfolio MSCI Global Stock Market ETF 0.01101 15.66 2.19607
iShares Core MSCI Total International Stock ETF 0.00514 4.37 3.25258
Vanguard ESG International Stock ETF 0 4.9 3.07501

スーパーバイザー 役職 支払い 生年
Dr. Krishna Prasad Chigurupati B.Sc. Chairman & MD 353.56M 1954 (71 年)
Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. Joint MD, CEO & Additional Director 94.56M 1963 (62 年)
Ms. Chaitanya Tummala Company Secretary & Compliance Officer 7.89M
Mr. Mukesh Surana Chief Financial Officer N/A 1981 (44 年)
Dr. P. V. Srinivas Chief Technology Officer N/A 1966 (59 年)
Mr. Sanjay Kumar President and Chief Strategy & Sustainability Officer N/A
Mr. Atul Dhavle B.E. Chief Human Resources Officer N/A 1970 (55 年)
Mr. Harsha Chigurupati BBA Executive Director 1983 (42 年)
Mr. Sethu Madhavan Sankaran Senior Vice President of API Manufacturing & Operations
Ms. Priyanka Chigurupati Whole-Time Director

住所: India, Hyderabad, My Home Hub - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.granulesindia.com